ctrl K

AI Score

Unlock

NewAmsterdam Pharma N.V. (NAMS)

AI Score

Unlock

21.77

-0.64 (-2.86%)

At close: Mar 28, 2025, 3:59 PM

21.45

-1.48%

After-hours: Mar 28, 2025, 05:37 PM EDT

NewAmsterdam Pharma Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	45.56M	12.76M	95.91M	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	45.56M	12.76M	95.91M	n/a	n/a
Operating Income	-176.29M	-165.73M	-3.32M	-30.73M	-5.43M
Interest Income	16.88M	10.22M	268.03K	361.1K	344K
Pretax Income	-241.6M	-160.25M	-21.14M	-36.71M	-5.75M
Net Income	-241.6M	-176.94M	-21.14M	-36.71M	-5.75M
Selling & General & Admin	70.45M	29.77M	18.22M	5.27M	1.38M
Research & Development	151.41M	159.42M	81.01M	25.46M	4.04M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	221.85M	197.06M	116.78M	36.35M	5.4M
Interest Expense	n/a	6.8M	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	4.06M	1.6M	858.39K	11K
Cost & Expenses	221.85M	183.23M	116.78M	36.35M	5.4M
Income Tax	-1K	27K	n/a	n/a	n/a
Shares Outstanding (Basic)	94.36M	82.16M	18.97M	17.75M	17.75M
Shares Outstanding (Diluted)	94.36M	82.16M	18.97M	17.75M	17.75M
EPS (Basic)	-2.56	-2.15	-1.11	-3.34	-1.15
EPS (Diluted)	-2.56	-2.15	-1.11	-3.34	-1.15
EBITDA	-241.49M	-176.86M	-3.31M	-30.73M	-5.43M
Depreciation & Amortization	-65.2M	49K	8.4K	4.39K	1K